Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...

After Philips issued a recall in mid-June of nearly two dozen models of its continuous and noncontinuous ventilators, ResMed has eagerly stepped up to fill in the market gap left by Philips’ absence.

Alphabet subsidiary Verily is teaming up with well-known sleep company ResMed to form a new venture that will focus on developing sleep apnea treatments and connected health products. The latest ...

As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

THE US and Australian-listed company's net profit grew three per cent in the three months to September to $US83.3 million, while revenue rose six per cent.

Add articles to your saved list and come back to them any time. Medical devices giant Resmed has been hit with a major patent infringement claim by the prestigious New York University, which alleges ...

It starts with snoring and sleep apnoea but it extends to heart attacks, diabetes, impotence, occupational health, obstetrics and many other areas. Australian-based ResMed is the global leader in this ...